International Business News - avastin http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Biotechnology company Genentech Inc. said Monday it asked the Food and Drug Administration to approve its drug Avastin as a secondary treatment for glioblastoma, an aggressive brain cancer. http://www.ibtimes.com/articles/20081103/genentech-seeks-avastin-approval-in-brain-cancer.htm Mon, 03 Nov 2008 12:50:20 EST Biotechnology company Genentech Inc. said Monday a late-stage study of Avastin focusing on early-stage colon cancer will continue, following an independent safety analysis. http://www.ibtimes.com/articles/20081020/genentech-restarts-early-stage-colon-cancer-study.htm Mon, 20 Oct 2008 16:47:34 EDT Genentech Inc. and OSI Pharmaceuticals Inc. said Monday a combination of two cancer drugs missed its primary goal in a clinical trial, failing to improve survival for patients with lung cancer. http://www.ibtimes.com/articles/20081006/avastin-tarceva-combo-fails-in-lung-cancer-trial.htm Mon, 06 Oct 2008 09:22:58 EDT Genentech Inc., the developer and maker of pharmaceutical products, said Thursday it expects final results from a clinical trial of a cancer drug Avastin in patients with colon cancer to be done by 2009, a year earlier than it previously forecasted. http://www.ibtimes.com/articles/20080516/genetech-avastin-colon-cancer-patients.htm Fri, 16 May 2008 22:16:10 EDT Genentech Inc. now expects final safety and effectiveness data from a trial of its cancer drug Avastin in colon cancer patients to be ready by 2009, a full year earlier than previously forecast. http://www.ibtimes.com/articles/20080516/genentech-sees-earlier-avastin-colon-cancer-data.htm Fri, 16 May 2008 10:45:07 EDT